Delivery Order SPE2DB20D2014-SPE2DB24FC83V
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $8,015.37, is for the delivery of 4,558,459,996 tablets of the medication Methylergonovine 0.2 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of September 15, 2022. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,032,696 units of the pharmaceutical drug Methylergonovine 0.2 mg Tablet in 28-count packages. The award has a ceiling value of $21,472.44 and a completion date of December 8, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not...
This federal contract award is for the delivery of 4,566,554,587 units of the medication Methylergonovine 0.2 mg tablets, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,933.55 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through November 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,501,441 units of the pharmaceutical product Methylergonovine 0.2 mg Tablet 28s. The $2,829.93 contract has a completion date of February 1, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg tablets, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price of $1,208.02 and a period of performance through April 11, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565749596 - Methylergonovine 0.2 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $2,127.78 and an Ultimate Completion Date of September 11, 2024. The contract is not a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The contract is part of a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4566370474 METHYLERGONOVINE 0.2 MG TABLET 12S, a pharmaceutical product, with a ceiling value of $2,109.54 and a completion date of November 8, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $6,322.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,563,416,314 units of the drug Methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of January 24, 2024 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of...